Analysis of host T-cell response in diffuse large B-cell lymphoma (DLBCL) and correlation with clinicopathological features
碩士 === 國立成功大學 === 臨床醫學研究所碩士在職專班 === 103 === Abstract 1. Objectives Immune system plays an important role to eliminate cancer cells. Cancer immunity is a complex mechanism and shows potentials for therapeutic targets. As a traditional model, tumor antigens, captured and processed by dendritic cells...
Main Authors: | ChenChang, 張珍 |
---|---|
Other Authors: | Kung-Chao Chang |
Format: | Others |
Language: | en_US |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/17395332202926751396 |
Similar Items
-
Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
by: Wenqi Zhang, et al.
Published: (2021-01-01) -
The regulatory mechanism of cell death by rigosertib in diffuse large B-cell lymphoma (DLBCL)
by: Yi-HanDai, et al.
Published: (2015) -
Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
by: Pengcheng Feng, et al.
Published: (2021-02-01) -
Interleukin 10 gene promoter polymorphism and risk of diffuse large B cell lymphoma (DLBCL)
by: Roba M. Talaat, et al.
Published: (2014-01-01) -
Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
by: Gleeson Michelle, et al.
Published: (2010-11-01)